$KIO

Pimentel Rudy purchased $41K of KIO

Pimentel Rudy (President) purchased 4,000 shares of KKR Income Opportunities Fund (KIO) at an average of $10.22 ($10.15–$10.30) across 4 trades over 2026-10-01 to 2026-10-08.

Original reporting
SEC EDGAR · Pimentel Rudy
Published Oct 14, 2026, 2:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 3:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KIO
Neutral
high confidence
Mentioned
$KIO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIONeutralLow
01

Why it matters

The modest purchase is unlikely to move the stock price materially.

02

Market read

A small insider buy in KIO, low trading relevance.

03

What to watch

Potential upcoming fund actions or distributions not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider trades; investors monitor them for signals of confidence.

Company-level read

Ticker impact

$KIONeutralHigh confidence
Context

President Rudy Pimentel purchased 4,000 shares of KIO for $40,890, increasing his stake to 15,154 shares.

Expected impact

minor upward pressure as market prices in the modest buy

Evidence & confidence

The transaction is a primary Form 4 filing, but the dollar amount is trivial for a listed fund.

Market effects

None significant; insider activity does not affect the broader fund sector.

Limited to US investors tracking KIO.

Minimal.

Counterpoint

The purchase could be a routine portfolio rebalancing, not a bullish signal.

Key entities

  • Rudy Pimentel

    President of KKR Income Opportunities Fund

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).